Two innovative pilot projects led by researchers at Washington University School of Medicine have received funding from the Chan Zuckerberg Initiative to address critical challenges in the fields of neurodegeneration and neuroscience.
Category: Corporations and Foundations
Two WashU faculty awarded Sloan Research Fellowships (Links to an external site)
Two early-career Washington University faculty members have been awarded a prestigious Sloan Research Fellowship: psychologist Zachariah Reagh, in Arts & Sciences, and neuroscientist Gaia Tavoni, at the School of Medicine.
Marks and McCrary receive funding from Gilead to expand blood-borne virus (HIV, HBV, HCV) screenings and linkage to care (Links to an external site)
Laura Marks, MD, Ph.D., and Madeline McCrary, MD, assistant professors of medicine at Washington University School of Medicine in St. Louis, have received a FOCUS grant from Gilead Sciences, Inc. to improve the rates of HIV, HCV, and HBV screenings and linkage to care. In the U.S., the FOCUS Program is a public health initiative that […]
Fehniger receives grant for trial of immunotherapy against melanoma (Links to an external site)
Todd A. Fehniger and colleagues Alice Y. Zhou, Ryan C. Fields, and George Ansstas have received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance.
Ashrafi receives Ben Barres Early Career Acceleration Award (Links to an external site)
Grant to support research on neurodegenerative disorders
V Foundation Award Given to Kelly Bolton, MD, PhD (Links to an external site)
Ackerman named a 2023 Klingenstein-Simons fellow (Links to an external site)
Sarah Ackerman, PhD, is one of 13 early-career scientists in the U.S. to receive the 2023 Klingenstein-Simons Fellowship Award in Neuroscience. She will receive a three-year $300,000 grant to pursue high-risk, cutting-edge research.
Dr. Tony Tsai has been named a 2023 Pew Scholar (Links to an external site)
Tony Tsai, MD, PhD, Assistant Professor of Developmental Biology, has been named a 2023 Pew Scholar in the Biomedical Sciences.
WashU, Eisai form drug discovery collaboration (Links to an external site)
Washington University School of Medicine in St. Louis and the pharmaceutical company Eisai Co. Ltd., headquartered in Japan, have formed a research collaboration aimed at developing new treatments for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative conditions.
WashU Medicine, BJC HealthCare partner with new company to accelerate lifesaving research (Links to an external site)
Washington University School of Medicine in St. Louis and BJC HealthCare are joining forces and partnering with CuriMeta, a new company that will accelerate lifesaving research in the fight against chronic and acute diseases that impact our communities.